Regulations (QSR) that require manufacturers to ensure that their devices are safe and effective.

FDA Guidance on Human Factors: Offers direction on the need for usability engineering studies to demonstrate that the design of the device minimizes the risks associated with use errors.

EU MDR and UKCA Regulations

The EU MDR (2017/745) and UKCA (UK regulations) necessitate that manufacturers consider usability in their risk management process. Key regulatory texts include:

• Article 3 of EU MDR: Mandates that devices must be designed to reduce the risk of use errors.
• Annex I – General Safety and Performance Requirements: Specifies that usability must be considered as part of product safety assessments.

Documentation Requirements

In forming the human factors file, comprehensive documentation is critical. This file must detail the HFE activities conducted during the design process, including:

• User Research: Data from user studies that inform the design process.
• Risk Management Documentation: Incorporate findings from usability tests and risk assessments, as outlined in ISO 14971.
• Usability Engineering File: Comprises the evidence required to demonstrate that the device is designed according to applicable standards and regulations.

Review/Approval Flow

The review process for HFE-related submissions generally involves several key stages:

• Pre-Submission Consultation: Engaging with regulatory agencies like the FDA or relevant Notified Bodies (NBs) in the EU can provide early feedback on proposed approaches to HFE studies.
• Submission of Human Factors File: This includes usability data, risk analyses, and validation studies as part of 510(k) submissions or Design Dossier/Technical Documentation for CE marking.
• Agency Review: Regulatory authority reviews submissions, assessing compliance with applicable guidelines and regulations.

Common Deficiencies

Regulatory approvals can be impeded by common deficiencies in the HFE submissions and documentation. These include:

• Inadequate Usability Testing: Failing to conduct robust usability tests or not adhering to prescribed methodologies can result in significant gaps in data.
• Lack of User-Centered Design Considerations: Ignoring user perspectives in the design phase may lead to the identification of usability issues too late in the development cycle.
• Insufficient Risk Assessment Documentation: Not thoroughly documenting risks associated with use errors can lead to non-compliance findings during regulatory review.

RA-specific Decision Points

When to File as Variation vs. New Application

Deciding whether to file a modification as a variation or a new application hinges on the extent of changes made during redesign influenced by HFE:

• Variation: If modifications substantially relate to usability but do not change the intended use or specifications significantly.
• New Application: When changes induce an additional clinical risk or significantly affect safety and efficacy profiles.

Justifying Bridging Data

In certain cases, bridging data may be warranted when existing evidence does not entirely overlap with the target user population or intended use environment. Justifications may include:

• Comparable User Demographics: Data from similar populations can be presented to support findings, but must include distinct differences in context.
• Analytical Approaches: Justify any gaps using statistical analyses and modeling to illustrate safety and efficacy remain acceptable.

Practical Tips for Regulatory Submissions

To facilitate successful documentation and compliance with relevant guidelines, consider the following:

• Engage Early with Regulatory Authorities: Proactive communication can clarify expectations and streamline subsequent filings.
• Conduct Comprehensive Training: Ensure that all team members involved in HFE understand regulatory requirements and methodologies.
• Iterative Testing: Implement iterative usability testing that allows continuous feedback and improvements into the design phase.

Conclusion

In conclusion, the integration of FDA human factors engineering principles with EU MDR and UKCA requirements showcases the necessity of a structured approach towards usability in combination products and medical devices. Understanding the regulatory landscape, documentation expectations, and a proactive approach can minimize common deficiencies and streamline approval processes. It is essential for regulatory affairs professionals to remain informed and utilize best practices in usability engineering throughout the product lifecycle to ensure compliance and enhance patient safety effectively.